SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filings

Filing date Form Description Filing Group View
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
REGDEX

REGDEX

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
View HTML
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
ARS

An annual report to security holders

Annual Filings
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML
4

Statement of changes in beneficial ownership of securities

3,4,5
View HTML

Data provided by Kaleidoscope.